New pill targets Tough-to-Treat cancers in groundbreaking trial

NCT ID NCT06616766

Summary

This early-stage study is testing a new oral medication called YH42946 for people with advanced solid tumors that have specific genetic changes (HER2 or EGFR mutations). The trial aims to find the safest dose and see if the drug can shrink tumors in 161 patients who have run out of standard treatment options. Researchers will first determine the maximum safe dose, then expand to see how well it works against specific cancer types.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Center, University of Ulsan

    RECRUITING

    Seoul, South Korea

    Contact

    Contact

  • Chungbuk National University Hospital

    RECRUITING

    Cheongju-si, North Chungcheong, 28644, South Korea

    Contact

    Contact

  • Next Oncology Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

    Contact

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam-si, Gyeonggi-do, 13620, South Korea

    Contact

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

    Contact

  • Severance Hospital, Yonsei University

    RECRUITING

    Seoul, 03722, South Korea

    Contact

  • The Catholic Univ. of Korea St. Vincent's Hospital

    RECRUITING

    Suwon, Gyeonggi-do, 16247, South Korea

    Contact

Conditions

Explore the condition pages connected to this study.